The number of men dying from prostate cancer in Great Britain is higher than the number of women dying from breast cancer – says the newest study from Prostate Cancer UK. After lung and bowel cancer, prostate cancer has now become the third most lethal type of cancer.
Prostate Cancer UK’s most recent evaluation has shown that in 2015, 11.819 men have died from prostate cancer, whereas it was 11,442 women dying of breast cancer. Advances in the diagnostics and therapy of breast cancer, and a higher interest for the disease in the scientific community are the reasons for better survival rates of breast cancer patients, say leading experts of the Charity. Therefore, there is a call to action to achieve advances in diagnostics and treatment options of prostate cancer.
Early detection can save lives
Many men with prostate cancer will not feel any symptoms; this is why a lot of incidences remain undiagnosed for a long time. Regular screenings are important to detect the cancer early and stop disease progression. A first indicator for prostate cancer is the PSA-test, which is the detection of the prostate-specific antigen in the blood. If the PSA value exceeds a certain level, more tests are necessary to evaluate the possibility of cancer. Trans-rectal biopsies are still frequently performed, even though they are not the most sensitive option. Magnetic resonance imaging (MRI) has a much higher sensitivity and is a non-invasive and pain-free procedure.
Prostate cancer symptoms
Due to the anatomy and position of the prostate, most symptoms are related to urination:
- Need for frequent urination
- Need to run to the toilet often – soemtimes called urge incontience
- Problems with starting the process of urination
- Weak urine stream
- Feeling that the bladder is not completely emptied.
Men over 50 years of age and those with family members who have had prostate cancer are in the higher risk category.
Do you think you may be at risk? Get in touch with us for a consultation or an MRI scan and an accurate diagnosis.